Key takeaways, audience Q&A, and EBAC evaluation

28 August 2026 (10:40 - 10:45)

Organised by:

Video

Sign in to view the resources

Slides

5 More presentations in this session

Presentation thumbnail

Introduction and overview

Professor G. Watts (Perth, AU)

Presentation thumbnail

Recognising clinical familial chylomicronemia syndrome: "the patient everyone thought was just noncompliant"

Professor K. Ray (London, GB)

Presentation thumbnail

Diagnosing familial chylomicronemia syndrome based on clinical criteria

Professor I. Gouni-Berthold (Cologne, DE)

Presentation thumbnail

A new treatment era for familial chylomicronemia syndrome: “what changes now?”

Professor G. Watts (Perth, AU)

Presentation thumbnail

Looking ahead at future targets

Professor G. Watts (Perth, AU)

Access the full session

Session thumbnail

The clinical face of familial chylomicronemia syndrome: improving recognition, diagnosis, and management

The Event

Event poster

ESC Congress 2026

28 August 2026 10:40 CET

You may be interested in

Congress Presentation

What's new in dyslipidaemia management? - discussion

28 August 2026

Congress Presentation

A randomised, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome

2 September 2024

Congress Presentation

Always expect the unexpected – familial hypercholesterolemia hiding beneath severe hypertriglyceridemia

30 August 2024

Congress Presentation

Chylomicronemia associated with APOA5 variants: report of two unrelated cases in Colombia with refractory severe hypertriglyceridemia.

30 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources